1. 219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy. (September 2015) Authors: Garajová, I.; Brandi, G.; Biasco, G.; Deserti, M.; Tavolari, S.; Palloni, A.; Verlicchi, L.; Le Large, T.; Giovannetti, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac). (April 2016) Authors: Meijer, L.L.; Garajová, I.; Caparello, C.; Le Large, T.Y.S.; Funel, N.; Vasile, E.; Giovannetti, E.; Zonderhuis, B.M.; Daams, F.; Kazemier, G. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma. (2019) Authors: Meijer, L.; Garajová, I.; Caparello, C.; Le Large, T.; Funel, N.; Vasile, E.; Zonderhuis, B.; Daams, F.; Giovannetti, E.; Kazemier, G. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Circulating microRNAs discriminate cholangiocarcinoma from pancreatic cancer. (September 2018) Authors: Meijer, L.L.; Puik, J.R.; Le Large, T.Y.S.; Heger, M.; Dijk, F.; Funel, N.; Garajová, I.; Giovannetti, E.; Kazemier, G. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗